{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Salvia verbenaca", "TNBS-induced colitis", "inflammation", "inflammatory bowel disease", "medicinal plants"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38136191", "DateRevised": {"Year": "2023", "Month": "12", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "12", "Day": "02"}], "Language": ["eng"], "ELocationID": ["2071", "10.3390/antiox12122071"], "Journal": {"ISSN": "2076-3921", "JournalIssue": {"Volume": "12", "Issue": "12", "PubDate": {"Year": "2023", "Month": "Dec", "Day": "02"}}, "Title": "Antioxidants (Basel, Switzerland)", "ISOAbbreviation": "Antioxidants (Basel)"}, "ArticleTitle": "The Antioxidant Properties of <i>Salvia verbenaca</i> Extract Contribute to Its Intestinal Antiinflammatory Effects in Experimental Colitis in Rats.", "Abstract": {"AbstractText": ["Inflammatory bowel disease (IBD) is a chronic gastrointestinal inflammation with unpredictable symptom fluctuations. While there is no effective cure for IBD, various treatments aim to manage symptoms and improve the quality of life for affected individuals. In recent years, there has been growing interest in the potential benefits of certain natural plants and herbs in the management of IBD. In this regard, this study aimed to evaluate the immunomodulatory and anti-inflammatory effects of a well-characterized extract of <i>Salvia verbenaca</i> (<i>S. verbenaca</i>) in an experimental model of colitis in rats. Interestingly, the daily administration of <i>S. verbenaca</i> (10 and 25 mg/kg) effectively alleviated colitis symptoms, as evidenced by reduced weight/length ratio and colonic damage. Moreover, it reduced oxidative stress markers (MPO and GSH), decreased pro-inflammatory cytokine expression (<i>Il-6</i>, <i>Il-12a</i>, <i>Il-1\u03b2</i>, <i>Il-23</i>, <i>Icam-1</i>, <i>Mcp-1</i>, <i>Cinc-1</i>), and preserved the integrity of the intestinal barrier (<i>Villin</i>, <i>Muc-2</i>, <i>Muc-3</i>). These effects suggest <i>S. verbenaca</i> extract could represent a potential complementary candidate to treat gastrointestinal disorders. Its beneficial actions can be related to its antioxidant properties as well as the downregulation of the immune response, which can result in the improvement in the intestine epithelial barrier."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain."}, {"Identifier": [], "Affiliation": "Instituto de Investigaci\u00f3n Biosanitaria de Granada (ibs. GRANADA), 18012 Granada, Spain."}, {"Identifier": [], "Affiliation": "Servicio de Digestivo, Hospital Universitario Virgen de las Nieves, 18014 Granada, Spain."}], "LastName": "Vezza", "ForeName": "Teresa", "Initials": "T"}, {"Identifier": ["0000-0003-1554-9226"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain."}, {"Identifier": [], "Affiliation": "Instituto de Investigaci\u00f3n Biosanitaria de Granada (ibs. GRANADA), 18012 Granada, Spain."}], "LastName": "Molina-Tijeras", "ForeName": "Jose Alberto", "Initials": "JA"}, {"Identifier": ["0000-0003-1927-0628"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain."}, {"Identifier": [], "Affiliation": "Instituto de Investigaci\u00f3n Biosanitaria de Granada (ibs. GRANADA), 18012 Granada, Spain."}], "LastName": "Rodr\u00edguez-Nogales", "ForeName": "Alba", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain."}], "LastName": "Garrido-Mesa", "ForeName": "Jose", "Initials": "J"}, {"Identifier": ["0000-0002-2613-4889"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Analytical Chemistry, Faculty of Science, University of Granada, 18071 Granada, Spain."}], "LastName": "C\u00e1diz-Gurrea", "ForeName": "Mar\u00eda de la Luz", "Initials": "ML"}, {"Identifier": ["0000-0002-5564-5338"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Analytical Chemistry, Faculty of Science, University of Granada, 18071 Granada, Spain."}], "LastName": "Segura-Carretero", "ForeName": "Antonio", "Initials": "A"}, {"Identifier": ["0000-0001-6700-8056"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, University of Granada, 18071 Granada, Spain."}], "LastName": "Gonz\u00e1lez-Tejero", "ForeName": "Mar\u00eda Reyes", "Initials": "MR"}, {"Identifier": ["0000-0001-9085-8147"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain."}, {"Identifier": [], "Affiliation": "Instituto de Investigaci\u00f3n Biosanitaria de Granada (ibs. GRANADA), 18012 Granada, Spain."}], "LastName": "Rodr\u00edguez-Cabezas", "ForeName": "Mar\u00eda Elena", "Initials": "ME"}, {"Identifier": ["0000-0001-6876-3782"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain."}, {"Identifier": [], "Affiliation": "Instituto de Investigaci\u00f3n Biosanitaria de Granada (ibs. GRANADA), 18012 Granada, Spain."}, {"Identifier": [], "Affiliation": "Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain."}], "LastName": "G\u00e1lvez", "ForeName": "Julio", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain."}, {"Identifier": [], "Affiliation": "Instituto de Investigaci\u00f3n Biosanitaria de Granada (ibs. GRANADA), 18012 Granada, Spain."}], "LastName": "Algieri", "ForeName": "Francesca", "Initials": "F"}], "GrantList": [{"GrantID": "AGR-6826", "Agency": "Junta de Andalucia", "Country": ""}, {"GrantID": "CTS 164", "Agency": "Junta de Andalucia", "Country": ""}, {"GrantID": "SAF2011-29648", "Agency": "Spanish Ministry of Economy and Competitivity", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Antioxidants (Basel)", "NlmUniqueID": "101668981", "ISSNLinking": "2076-3921"}, "CoiStatement": "The authors declare no conflict of interest. "}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bruner L.P., White A.M., Proksell S. Inflammatory Bowel Disease. Prim. Care. 2023;50:411\u2013427. doi: 10.1016/j.pop.2023.03.009.", "ArticleIdList": ["10.1016/j.pop.2023.03.009", "37516511"]}, {"Citation": "Zhang Y.Z., Li Y.Y. Inflammatory bowel disease: Pathogenesis. World J. Gastroenterol. 2014;20:91\u201399. doi: 10.3748/wjg.v20.i1.91.", "ArticleIdList": ["10.3748/wjg.v20.i1.91", "PMC3886036", "24415861"]}, {"Citation": "Burisch J. Crohn\u2019s disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort. Dan. Med. J. 2014;61:B4778.", "ArticleIdList": ["24393595"]}, {"Citation": "Guan Q., Zhang J. Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease. Mediat. Inflamm. 2017;2017:4810258. doi: 10.1155/2017/4810258.", "ArticleIdList": ["10.1155/2017/4810258", "PMC5379128", "28420941"]}, {"Citation": "Elhag D.A., Kumar M., Saadaoui M., Akobeng A.K., Al-Mudahka F., Elawad M., Al Khodor S. Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response. Int. J. Mol. Sci. 2022;23:6966. doi: 10.3390/ijms23136966.", "ArticleIdList": ["10.3390/ijms23136966", "PMC9266456", "35805965"]}, {"Citation": "Juillerat P., Grueber M.M., Ruetsch R., Santi G., Vuillemoz M., Michetti P. Positioning biologics in the treatment of IBD: A practical guide\u2014Which mechanism of action for whom? Curr. Res. Pharmacol. Drug Discov. 2022;3:100104. doi: 10.1016/j.crphar.2022.100104.", "ArticleIdList": ["10.1016/j.crphar.2022.100104", "PMC9092374", "35570855"]}, {"Citation": "Quezada S.M., McLean L.P., Cross R.K. Adverse events in IBD therapy: The 2018 update. Expert Rev. Gastroenterol. Hepatol. 2018;12:1183\u20131191. doi: 10.1080/17474124.2018.1545574.", "ArticleIdList": ["10.1080/17474124.2018.1545574", "30791788"]}, {"Citation": "Holleran G., Scaldaferri F., Gasbarrini A., Curro D. Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double-blind randomised controlled trials. Phytother. Res. 2020;34:77\u201393. doi: 10.1002/ptr.6517.", "ArticleIdList": ["10.1002/ptr.6517", "31701598"]}, {"Citation": "Algieri F., Rodriguez-Nogales A., Rodriguez-Cabezas M.E., Risco S., Ocete M.A., Galvez J. Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review. Mediat. Inflamm. 2015;2015:179616. doi: 10.1155/2015/179616.", "ArticleIdList": ["10.1155/2015/179616", "PMC4630406", "26576073"]}, {"Citation": "Vezza T., Algieri F., Rodriguez-Nogales A., Garrido-Mesa J., Utrilla M.P., Talhaoui N., Gomez-Caravaca A.M., Segura-Carretero A., Rodriguez-Cabezas M.E., Monteleone G., et al. Immunomodulatory properties of Olea europaea leaf extract in intestinal inflammation. Mol. Nutr. Food Res. 2017;61:1601066. doi: 10.1002/mnfr.201601066.", "ArticleIdList": ["10.1002/mnfr.201601066", "28731213"]}, {"Citation": "Wang L., Ma R., Liu C., Liu H., Zhu R., Guo S., Tang M., Li Y., Niu J., Fu M., et al. Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases. Curr. Pharm. Des. 2017;23:1077\u20131097. doi: 10.2174/1381612822666161010105242.", "ArticleIdList": ["10.2174/1381612822666161010105242", "PMC5421141", "27748194"]}, {"Citation": "Wang H., Chen X.P., Qiu F.Z. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats. Hepatobiliary Pancreat. Dis. Int. 2003;2:391\u2013396.", "ArticleIdList": ["14599946"]}, {"Citation": "Kang D.G., Oh H., Sohn E.J., Hur T.Y., Lee K.C., Kim K.J., Kim T.Y., Lee H.S. Lithospermic acid B isolated from Salvia miltiorrhiza ameliorates ischemia/reperfusion-induced renal injury in rats. Life Sci. 2004;75:1801\u20131816. doi: 10.1016/j.lfs.2004.02.034.", "ArticleIdList": ["10.1016/j.lfs.2004.02.034", "15302225"]}, {"Citation": "Jalalipour M., Yegdaneh A., Talebi A., Minaiyan M. Salvia officinalis leaf extracts protect against acute colitis in rats. Res. Pharm. Sci. 2022;17:350\u2013359. doi: 10.4103/1735-5362.350236.", "ArticleIdList": ["10.4103/1735-5362.350236", "PMC9400462", "36034079"]}, {"Citation": "Bonesi M., Loizzo M.R., Acquaviva R., Malfa G.A., Aiello F., Tundis R. Anti-inflammatory and Antioxidant Agents from Salvia Genus (Lamiaceae): An Assessment of the Current State of Knowledge. Antiinflamm. Antiallergy Agents Med. Chem. 2017;16:70\u201386. doi: 10.2174/1871523016666170502121419.", "ArticleIdList": ["10.2174/1871523016666170502121419", "28464779"]}, {"Citation": "Silva I., Solas J., Pinto R., Mateus V. Chronic Experimental Model of TNBS-Induced Colitis to Study Inflammatory Bowel Disease. Int. J. Mol. Sci. 2022;23:4739. doi: 10.3390/ijms23094739.", "ArticleIdList": ["10.3390/ijms23094739", "PMC9105049", "35563130"]}, {"Citation": "Delgado-Torre M.P., Ferreiro-Vera C., Priego-Capote F., Perez-Juan P.M., Luque de Castro M.D. Comparison of accelerated methods for the extraction of phenolic compounds from different vine-shoot cultivars. J. Agric. Food Chem. 2012;60:3051\u20133060. doi: 10.1021/jf205078k.", "ArticleIdList": ["10.1021/jf205078k", "22372567"]}, {"Citation": "Cadiz-Gurrea M.L., Pinto D., Delerue-Matos C., Rodrigues F. Olive Fruit and Leaf Wastes as Bioactive Ingredients for Cosmetics-A Preliminary Study. Antioxidants. 2021;10:245. doi: 10.3390/antiox10020245.", "ArticleIdList": ["10.3390/antiox10020245", "PMC7914505", "33562523"]}, {"Citation": "Ribeiro B., Valentao P., Baptista P., Seabra R.M., Andrade P.B. Phenolic compounds, organic acids profiles and antioxidative properties of beefsteak fungus (Fistulina hepatica) Food Chem. Toxicol. 2007;45:1805\u20131813. doi: 10.1016/j.fct.2007.03.015.", "ArticleIdList": ["10.1016/j.fct.2007.03.015", "17493733"]}, {"Citation": "Camuesco D., Peran L., Comalada M., Nieto A., Di Stasi L.C., Rodriguez-Cabezas M.E., Concha A., Zarzuelo A., Galvez J. Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis. Inflamm. Bowel Dis. 2005;11:265\u2013271. doi: 10.1097/01.MIB.0000160808.30988.d9.", "ArticleIdList": ["10.1097/01.MIB.0000160808.30988.d9", "15735433"]}, {"Citation": "Krawisz J.E., Sharon P., Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology. 1984;87:1344\u20131350. doi: 10.1016/0016-5085(84)90202-6.", "ArticleIdList": ["10.1016/0016-5085(84)90202-6", "6092199"]}, {"Citation": "Anderson M.E. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 1985;113:548\u2013555. doi: 10.1016/s0076-6879(85)13073-9.", "ArticleIdList": ["10.1016/s0076-6879(85)13073-9", "4088074"]}, {"Citation": "Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008;3:1101\u20131108. doi: 10.1038/nprot.2008.73.", "ArticleIdList": ["10.1038/nprot.2008.73", "18546601"]}, {"Citation": "Cross R.K., Wilson K.T. Nitric oxide in inflammatory bowel disease. Inflamm. Bowel Dis. 2003;9:179\u2013189. doi: 10.1097/00054725-200305000-00006.", "ArticleIdList": ["10.1097/00054725-200305000-00006", "12792224"]}, {"Citation": "Ko J.K., Auyeung K.K. Inflammatory bowel disease: Etiology, pathogenesis and current therapy. Curr. Pharm. Des. 2014;20:1082\u20131096. doi: 10.2174/13816128113199990416.", "ArticleIdList": ["10.2174/13816128113199990416", "23782147"]}, {"Citation": "Liu S., Zhao W., Lan P., Mou X. The microbiome in inflammatory bowel diseases: From pathogenesis to therapy. Protein Cell. 2021;12:331\u2013345. doi: 10.1007/s13238-020-00745-3.", "ArticleIdList": ["10.1007/s13238-020-00745-3", "PMC8106558", "32601832"]}, {"Citation": "Cai Z., Wang S., Li J. Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Front. Med. 2021;8:765474. doi: 10.3389/fmed.2021.765474.", "ArticleIdList": ["10.3389/fmed.2021.765474", "PMC8720971", "34988090"]}, {"Citation": "Ganji-Arjenaki M., Rafieian-Kopaei M. Phytotherapies in inflammatory bowel disease. J. Res. Med. Sci. 2019;24:42. doi: 10.4103/jrms.JRMS_590_17.", "ArticleIdList": ["10.4103/jrms.JRMS_590_17", "PMC6540767", "31160909"]}, {"Citation": "Lin Z., Wu H., Fu Y., Dai S. Application of Herbaceous Medications for Inflammatory Bowel Disease as a Complementary and Alternative Therapy. Inflamm. Bowel Dis. 2019;25:1886\u20131895. doi: 10.1093/ibd/izz190.", "ArticleIdList": ["10.1093/ibd/izz190", "31504527"]}, {"Citation": "Tian T., Wang Z., Zhang J. Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies. Oxid. Med. Cell Longev. 2017;2017:4535194. doi: 10.1155/2017/4535194.", "ArticleIdList": ["10.1155/2017/4535194", "PMC5506473", "28744337"]}, {"Citation": "Balmus I.M., Ciobica A., Trifan A., Stanciu C. The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models. Saudi J. Gastroenterol. 2016;22:3\u201317. doi: 10.4103/1319-3767.173753.", "ArticleIdList": ["10.4103/1319-3767.173753", "PMC4763525", "26831601"]}, {"Citation": "Aratani Y. Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Arch. Biochem. Biophys. 2018;640:47\u201352. doi: 10.1016/j.abb.2018.01.004.", "ArticleIdList": ["10.1016/j.abb.2018.01.004", "29336940"]}, {"Citation": "Danese S., Gasbarrini A. Chemokines in inflammatory bowel disease. J. Clin. Pathol. 2005;58:1025\u20131027. doi: 10.1136/jcp.2005.030916.", "ArticleIdList": ["10.1136/jcp.2005.030916", "PMC1770732", "16189145"]}, {"Citation": "Danese S., Semeraro S., Marini M., Roberto I., Armuzzi A., Papa A., Gasbarrini A. Adhesion molecules in inflammatory bowel disease: Therapeutic implications for gut inflammation. Dig. Liver Dis. 2005;37:811\u2013818. doi: 10.1016/j.dld.2005.03.013.", "ArticleIdList": ["10.1016/j.dld.2005.03.013", "16168725"]}, {"Citation": "Ohtsuka Y., Lee J., Stamm D.S., Sanderson I.R. MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut. 2001;49:526\u2013533. doi: 10.1136/gut.49.4.526.", "ArticleIdList": ["10.1136/gut.49.4.526", "PMC1728474", "11559650"]}, {"Citation": "Holmes E.W., Yong S.L., Eiznhamer D., Keshavarzian A. Glutathione content of colonic mucosa: Evidence for oxidative damage in active ulcerative colitis. Dig. Dis. Sci. 1998;43:1088\u20131095. doi: 10.1023/A:1018899222258.", "ArticleIdList": ["10.1023/A:1018899222258", "9590426"]}, {"Citation": "Friedrich M., Pohin M., Powrie F. Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease. Immunity. 2019;50:992\u20131006. doi: 10.1016/j.immuni.2019.03.017.", "ArticleIdList": ["10.1016/j.immuni.2019.03.017", "30995511"]}, {"Citation": "Papadakis K.A., Targan S.R. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 2000;51:289\u2013298. doi: 10.1146/annurev.med.51.1.289.", "ArticleIdList": ["10.1146/annurev.med.51.1.289", "10774465"]}, {"Citation": "Neurath M.F. Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 2014;14:329\u2013342. doi: 10.1038/nri3661.", "ArticleIdList": ["10.1038/nri3661", "24751956"]}, {"Citation": "Slebioda T.J., Kmiec Z. Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease. Mediat. Inflamm. 2014;2014:325129. doi: 10.1155/2014/325129.", "ArticleIdList": ["10.1155/2014/325129", "PMC4087264", "25045210"]}, {"Citation": "da Cunha F.M., Duma D., Assreuy J., Buzzi F.C., Niero R., Campos M.M., Calixto J.B. Caffeic acid derivatives: In vitro and in vivo anti-inflammatory properties. Free Radic. Res. 2004;38:1241\u20131253. doi: 10.1080/10715760400016139.", "ArticleIdList": ["10.1080/10715760400016139", "15621702"]}, {"Citation": "Vezza T., Rodriguez-Nogales A., Algieri F., Utrilla M.P., Rodriguez-Cabezas M.E., Galvez J. Flavonoids in Inflammatory Bowel Disease: A Review. Nutrients. 2016;8:211. doi: 10.3390/nu8040211.", "ArticleIdList": ["10.3390/nu8040211", "PMC4848680", "27070642"]}, {"Citation": "Xiao Z., Liu W., Mu Y.P., Zhang H., Wang X.N., Zhao C.Q., Chen J.M., Liu P. Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage. Front. Pharmacol. 2020;11:572373. doi: 10.3389/fphar.2020.572373.", "ArticleIdList": ["10.3389/fphar.2020.572373", "PMC7741185", "33343348"]}, {"Citation": "Oz H.S., Chen T., de Villiers W.J. Green Tea Polyphenols and Sulfasalazine have Parallel Anti-Inflammatory Properties in Colitis Models. Front. Immunol. 2013;4:132. doi: 10.3389/fimmu.2013.00132.", "ArticleIdList": ["10.3389/fimmu.2013.00132", "PMC3672863", "23761791"]}, {"Citation": "Azuma T., Shigeshiro M., Kodama M., Tanabe S., Suzuki T. Supplemental naringenin prevents intestinal barrier defects and inflammation in colitic mice. J. Nutr. 2013;143:827\u2013834. doi: 10.3945/jn.113.174508.", "ArticleIdList": ["10.3945/jn.113.174508", "23596159"]}, {"Citation": "Camuesco D., Comalada M., Rodriguez-Cabezas M.E., Nieto A., Lorente M.D., Concha A., Zarzuelo A., Galvez J. The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br. J. Pharmacol. 2004;143:908\u2013918. doi: 10.1038/sj.bjp.0705941.", "ArticleIdList": ["10.1038/sj.bjp.0705941", "PMC1575937", "15533892"]}, {"Citation": "Dou W., Zhang J., Ren G., Ding L., Sun A., Deng C., Wu X., Wei X., Mani S., Wang Z. Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-kappaB and MAPK signaling inactivation. Int. Immunopharmacol. 2014;23:170\u2013178. doi: 10.1016/j.intimp.2014.08.025.", "ArticleIdList": ["10.1016/j.intimp.2014.08.025", "PMC4570622", "25194678"]}, {"Citation": "Comalada M., Camuesco D., Sierra S., Ballester I., Xaus J., Galvez J., Zarzuelo A. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur. J. Immunol. 2005;35:584\u2013592. doi: 10.1002/eji.200425778.", "ArticleIdList": ["10.1002/eji.200425778", "15668926"]}, {"Citation": "Yu F.Y., Huang S.G., Zhang H.Y., Ye H., Chi H.G., Zou Y., Lv R.X., Zheng X.B. Effects of baicalin in CD4 + CD29 + T cell subsets of ulcerative colitis patients. World J. Gastroenterol. 2014;20:15299\u201315309. doi: 10.3748/wjg.v20.i41.15299.", "ArticleIdList": ["10.3748/wjg.v20.i41.15299", "PMC4223263", "25386078"]}, {"Citation": "Schreiber S., Rosenstiel P., Hampe J., Nikolaus S., Groessner B., Schottelius A., Kuhbacher T., Hamling J., Folsch U.R., Seegert D. Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut. 2002;51:379\u2013385. doi: 10.1136/gut.51.3.379.", "ArticleIdList": ["10.1136/gut.51.3.379", "PMC1773344", "12171960"]}, {"Citation": "Pedersen J., Coskun M., Soendergaard C., Salem M., Nielsen O.H. Inflammatory pathways of importance for management of inflammatory bowel disease. World J. Gastroenterol. 2014;20:64\u201377. doi: 10.3748/wjg.v20.i1.64.", "ArticleIdList": ["10.3748/wjg.v20.i1.64", "PMC3886034", "24415859"]}, {"Citation": "Hossen I., Hua W., Ting L., Mehmood A., Jingyi S., Duoxia X., Yanping C., Hongqing W., Zhipeng G., Kaiqi Z., et al. Phytochemicals and inflammatory bowel disease: A review. Crit. Rev. Food Sci. Nutr. 2020;60:1321\u20131345. doi: 10.1080/10408398.2019.1570913.", "ArticleIdList": ["10.1080/10408398.2019.1570913", "30729797"]}, {"Citation": "Lechuga S., Ivanov A.I. Disruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanisms. Biochim. Biophys. Acta Mol. Cell Res. 2017;1864:1183\u20131194. doi: 10.1016/j.bbamcr.2017.03.007.", "ArticleIdList": ["10.1016/j.bbamcr.2017.03.007", "PMC5507344", "28322932"]}, {"Citation": "Chelakkot C., Ghim J., Ryu S.H. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp. Mol. Med. 2018;50:1\u20139. doi: 10.1038/s12276-018-0126-x.", "ArticleIdList": ["10.1038/s12276-018-0126-x", "PMC6095905", "30115904"]}, {"Citation": "Martini E., Krug S.M., Siegmund B., Neurath M.F., Becker C. Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease. Cell Mol. Gastroenterol. Hepatol. 2017;4:33\u201346. doi: 10.1016/j.jcmgh.2017.03.007.", "ArticleIdList": ["10.1016/j.jcmgh.2017.03.007", "PMC5439240", "28560287"]}, {"Citation": "Feng P.P., Fang X.S., Zhao S.H., Fu J.Y., Zhang H.T., Yi Y.L., Li C.Y., Jiang C.L., Chen D.P. Salvianolic acid B decreases interleukin-1beta-induced colitis recurrence in mice. Chin. Med. J. 2020;133:1436\u20131444. doi: 10.1097/CM9.0000000000000773.", "ArticleIdList": ["10.1097/CM9.0000000000000773", "PMC7339324", "32472783"]}, {"Citation": "Einerhand A.W., Renes I.B., Makkink M.K., van der Sluis M., Buller H.A., Dekker J. Role of mucins in inflammatory bowel disease: Important lessons from experimental models. Eur. J. Gastroenterol. Hepatol. 2002;14:757\u2013765. doi: 10.1097/00042737-200207000-00008.", "ArticleIdList": ["10.1097/00042737-200207000-00008", "12169985"]}, {"Citation": "Van der Sluis M., De Koning B.A., De Bruijn A.C., Velcich A., Meijerink J.P., Van Goudoever J.B., Buller H.A., Dekker J., Van Seuningen I., Renes I.B., et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology. 2006;131:117\u2013129. doi: 10.1053/j.gastro.2006.04.020.", "ArticleIdList": ["10.1053/j.gastro.2006.04.020", "16831596"]}, {"Citation": "Wang Y., Srinivasan K., Siddiqui M.R., George S.P., Tomar A., Khurana S. A novel role for villin in intestinal epithelial cell survival and homeostasis. J. Biol. Chem. 2008;283:9454\u20139464. doi: 10.1074/jbc.M707962200.", "ArticleIdList": ["10.1074/jbc.M707962200", "18198174"]}, {"Citation": "Galvez J., Coelho G., Crespo M.E., Cruz T., Rodriguez-Cabezas M.E., Concha A., Gonzalez M., Zarzuelo A. Intestinal anti-inflammatory activity of morin on chronic experimental colitis in the rat. Aliment. Pharmacol. Ther. 2001;15:2027\u20132039. doi: 10.1046/j.1365-2036.2001.01133.x.", "ArticleIdList": ["10.1046/j.1365-2036.2001.01133.x", "11736735"]}, {"Citation": "Sanchez de Medina F., Galvez J., Romero J.A., Zarzuelo A. Effect of quercitrin on acute and chronic experimental colitis in the rat. J. Pharmacol. Exp. Ther. 1996;278:771\u2013779.", "ArticleIdList": ["8768730"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "10", "Day": "24"}, {"Year": "2023", "Month": "11", "Day": "25"}, {"Year": "2023", "Month": "11", "Day": "30"}, {"Year": "2023", "Month": "12", "Day": "23", "Hour": "12", "Minute": "44"}, {"Year": "2023", "Month": "12", "Day": "23", "Hour": "12", "Minute": "43"}, {"Year": "2023", "Month": "12", "Day": "23", "Hour": "1", "Minute": "2"}, {"Year": "2023", "Month": "12", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["38136191", "PMC10741154", "10.3390/antiox12122071", "antiox12122071"]}}], "PubmedBookArticle": []}